Global Biopharmaceutical Logistics Market Size Study, By Supply Chain (Cold Chain, Non-Cold Chain), By Services (Transportation Mode, Warehousing, Others), and Regional Forecasts 2022-2032

Description

The Global Biopharmaceutical Logistics Market, valued at USD 125.47 billion in 2023, is projected to grow significantly with a CAGR of 5.93% over the forecast period from 2024 to 2032. The growth is driven by the increasing demand for specialized logistics services, particularly for temperature-sensitive biopharmaceuticals, as well as the surge in the production of biologics and vaccines. With an emphasis on ensuring product integrity through the cold chain, logistics providers are increasingly investing in advanced technologies such as IoT sensors, real-time tracking, and AI-powered predictive maintenance systems.

The COVID-19 pandemic highlighted the critical importance of resilient and efficient supply chains in the pharmaceutical industry. This spurred innovation and growth within the biopharmaceutical logistics market as companies and governments sought to improve vaccine distribution and transportation of critical healthcare products. The demand for cold chain logistics, in particular, has expanded as biopharmaceuticals like vaccines, gene therapies, and complex biologics require controlled environments during transit.

North America is expected to dominate the market, benefiting from a well-established pharmaceutical industry and advanced logistics infrastructure. Meanwhile, Asia-Pacific is projected to exhibit the fastest growth, driven by increasing pharmaceutical production, the rise of generics, and improving healthcare infrastructure. The region's expanding cold chain logistics capabilities and investments in technology are fueling its rapid growth.

Key market players include:

DHL International GmbH
United Parcel Service of America Inc.
SF Express
Hitachi Transport System
AmerisourceBergen Corporation
Kerry Logistics Network Limited
Kuehne and Nagel
Agility
DB Schenker
Company 10

The detailed segments and sub-segments of the market are explained below:

By Supply Chain:

Cold Chain
Non-Cold Chain

By Services:

Transportation Mode
Warehousing
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year: 2022
Base year: 2023
Forecast period: 2024 to 2032

Key Takeaways:

Market estimates and forecasts for 10 years (2022-2032)
Detailed regional analysis with country-level breakdowns
Competitive landscape with information on major market players
Analysis of key strategies and recommendations for future market approaches
Emphasis on technological advancements and their impact on market dynamics

Chapter 1: Global Biopharmaceutical Logistics Market Executive Summary

1.1. Global Biopharmaceutical Logistics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Supply Chain
- 1.3.2. By Services
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion

Chapter 2: Global Biopharmaceutical Logistics Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply-Side Analysis
  - 2.3.3.1. Regulatory Environment
  - 2.3.3.2. Technological Advancements
- 2.3.4. Demand-Side Analysis
  - 2.3.4.1. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3: Global Biopharmaceutical Logistics Market Dynamics

3.1. Market Drivers
- 3.1.1. Surge in Demand for Temperature-Controlled Logistics
- 3.1.2. Growth of Biologics and Complex Therapeutics
- 3.1.3. Technological Advancements in Supply Chain Management
3.2. Market Challenges
- 3.2.1. High Operational Costs and Regulatory Compliance
- 3.2.2. Complex Logistics Requirements for Biopharmaceuticals
- 3.2.3. Workforce Shortages in Emerging Markets
3.3. Market Opportunities
- 3.3.1. Growth of Emerging Markets and Globalization
- 3.3.2. Expanding Cold Chain Infrastructure

Chapter 4: Global Biopharmaceutical Logistics Market Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Analyst Recommendations & Conclusion

Chapter 5: Global Biopharmaceutical Logistics Market Size & Forecasts by Supply Chain (2022-2032)

5.1. Segment Dashboard
5.2. Global Biopharmaceutical Logistics Market: Supply Chain Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Cold Chain
- 5.2.2. Non-Cold Chain

Chapter 6: Global Biopharmaceutical Logistics Market Size & Forecasts by Services (2022-2032)

6.1. Segment Dashboard
6.2. Global Biopharmaceutical Logistics Market: Services Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Transportation Mode
- 6.2.2. Warehousing
- 6.2.3. Others

Chapter 7: Global Biopharmaceutical Logistics Market Size & Forecasts by Region (2022-2032)

7.1. North America Biopharmaceutical Logistics Market
- 7.1.1. U.S. Biopharmaceutical Logistics Market
  - 7.1.1.1. Supply Chain breakdown size & forecasts, 2022-2032
  - 7.1.1.2. Services breakdown size & forecasts, 2022-2032
- 7.1.2. Canada Biopharmaceutical Logistics Market
7.2. Europe Biopharmaceutical Logistics Market
- 7.2.1. UK Biopharmaceutical Logistics Market
- 7.2.2. Germany Biopharmaceutical Logistics Market
- 7.2.3. France Biopharmaceutical Logistics Market
- 7.2.4. Spain Biopharmaceutical Logistics Market
- 7.2.5. Italy Biopharmaceutical Logistics Market
- 7.2.6. Rest of Europe Biopharmaceutical Logistics Market
7.3. Asia-Pacific Biopharmaceutical Logistics Market
- 7.3.1. China Biopharmaceutical Logistics Market
- 7.3.2. India Biopharmaceutical Logistics Market
- 7.3.3. Japan Biopharmaceutical Logistics Market
- 7.3.4. Australia Biopharmaceutical Logistics Market
- 7.3.5. South Korea Biopharmaceutical Logistics Market
- 7.3.6. Rest of Asia-Pacific Biopharmaceutical Logistics Market
7.4. Latin America Biopharmaceutical Logistics Market
- 7.4.1. Brazil Biopharmaceutical Logistics Market
- 7.4.2. Mexico Biopharmaceutical Logistics Market
- 7.4.3. Rest of Latin America Biopharmaceutical Logistics Market
7.5. Middle East & Africa Biopharmaceutical Logistics Market
- 7.5.1. Saudi Arabia Biopharmaceutical Logistics Market
- 7.5.2. South Africa Biopharmaceutical Logistics Market
- 7.5.3. Rest of Middle East & Africa Biopharmaceutical Logistics Market

Chapter 8: Competitive Intelligence

8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. DHL International GmbH
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. United Parcel Service of America Inc.
- 8.3.3. SF Express
- 8.3.4. Hitachi Transport System
- 8.3.5. AmerisourceBergen Corporation
- 8.3.6. Kerry Logistics Network Limited
- 8.3.7. Kuehne and Nagel
- 8.3.8. Agility
- 8.3.9. DB Schenker

Chapter 9: Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes